William Blair Expects Stronger Earnings for Krystal Biotech
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Research analysts at William Blair increased their Q3 2025 earnings per share (EPS) estimates for shares of Krystal Biotech in a research report issued to clients and investors on Wednesday, April 2nd. William Blair analyst S. Corwin now forecasts that the company will post earnings of $1.84 […]
